Angiogenesis Inhibition and Choroidal Neovascularization Suppression by Sustained Delivery of an Integrin Antagonist, EMD478761
Investigative Ophthalmology & Visual Science2007Vol. 48(11), pp. 5184–5184
Citations Over TimeTop 15% of 2007 papers
Abstract
Sustained delivery of EMD478761demonstrates potent antiangiogenic properties in vivo. These results suggest that an EMD478761 implant may be beneficial in the treatment of neovascular ocular diseases.
Related Papers
- → The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis(1996)191 cited
- → Quantitation of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane(1994)248 cited
- → The Chick Chorioallantoic Membrane as an In Vivo Angiogenesis Model(2003)35 cited
- [Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis].(2007)
- Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis(2007)